openPR Logo
Press release

Mycobacterium Tuberculosis PCR Kits Market to Hit USD 985.1 Million by 2035 with Diagnostics Innovation Driving Growth

10-08-2025 01:53 PM CET | Health & Medicine

Press release from: Future Market Insights

Mycobacterium Tuberculosis PCR Kits Market

Mycobacterium Tuberculosis PCR Kits Market

The global fight against tuberculosis (TB) is set to experience a major transformation, as the Mycobacterium tuberculosis PCR detection kits market expands from USD 616.4 million in 2025 to USD 985.1 million by 2035. This trajectory, marked by a compound annual growth rate (CAGR) of 4.8%, reflects how advancements in molecular diagnostics and global health initiatives are shaping the future of TB testing.

Inflection point mapping of the market's growth reveals three key stages. Between 2020 and 2025, revenues rose from USD 487.6 million to USD 616.4 million, showing the first wave of adoption. This stage was powered by increased awareness, expanded diagnostic capacities, and international TB control campaigns. From 2025 to 2030, the market accelerates further, reaching USD 779.2 million, driven by integration of PCR kits into public health systems and broader diagnostic networks. Finally, between 2030 and 2035, the market grows to USD 985.1 million, showing signs of maturity where accessibility, replacement demand, and integration into molecular platforms sustain growth.

Why PCR Detection Kits Are Vital in TB Control

Tuberculosis remains a global health challenge, and the demand for precise, rapid, and scalable diagnostic tools has never been greater. PCR detection kits provide the sensitivity and speed necessary to detect TB pathogens early, guide treatment, and improve public health outcomes. Their integration into routine healthcare and community-level diagnostic systems makes them indispensable for global TB eradication programs.

Real-time PCR kits, in particular, dominate the product landscape, accounting for 64% of the market in 2025. Their ability to deliver rapid results, support drug resistance detection, and integrate with automated lab workflows has made them the preferred choice across clinical laboratories and hospitals worldwide. Clinical diagnosis applications represent 71% of overall demand, underscoring the central role of these kits in patient care.

Market Drivers and Innovation Pathways

The growth of the PCR detection kits market is being shaped by several converging forces. Global TB elimination initiatives are pushing governments, NGOs, and healthcare providers to expand testing capabilities. Advances in molecular diagnostics and laboratory automation are redefining detection accuracy and efficiency. Hospitals and reference laboratories are increasingly turning to real-time PCR kits to accelerate testing and improve treatment monitoring.

At the same time, challenges such as cost pressures, varying regulatory standards, and quality control requirements highlight the importance of continuous innovation. Manufacturers are responding by developing intelligent, automated systems that improve workflow efficiency and ensure clinical reliability, thereby creating sustainable value for healthcare systems and patients alike.

Established Leaders and New Innovators

The competitive landscape is both broad and dynamic. Industry leaders like QIAGEN, Norgen Biotek, CerTest Biotec, GeneProof, HiMedia Laboratories, and Fosun Pharma have set benchmarks for innovation, global reach, and diagnostic accuracy. Their advanced platforms and robust regulatory expertise make them trusted partners for large-scale health programs.

Meanwhile, Sansure Biotech, Solgent, INtRON Biotechnology, Zhejiang Orient Gene Biotech, Zeesan Biotech, and Mylab Discovery Solutions represent the new wave of agile manufacturers. They are actively innovating in real-time PCR technology, offering cost-effective solutions tailored to emerging markets, and expanding into regions where access to diagnostics is critical. Companies like Primerdesign, ELITechGroup, Bioneer, NZYTech, BioSellal, and Hangzhou Bioer Technology are further enriching the ecosystem with specialized kits and novel molecular architectures.

Together, these players-both established and emerging-are driving the industry toward a future where high-quality TB diagnostics become universally accessible.

Regional Growth Highlights

The market's global outlook reflects diverse opportunities across regions. China leads with a CAGR of 6.5%, fueled by massive investments in healthcare infrastructure and government-led TB control programs. India follows with 6.0%, propelled by its high TB burden and increasing adoption of molecular diagnostics. Germany at 5.5% demonstrates how advanced healthcare systems are integrating innovative PCR solutions into mainstream diagnostic workflows.

Other markets also show promising expansion. Brazil (5.0%) benefits from rising healthcare investments, while the United States (4.6%) continues to innovate with advanced clinical testing. The United Kingdom (4.1%) and Japan (3.6%) represent mature but stable markets, where precision and regulatory compliance drive adoption. By 2035, Europe's market is projected to rise from USD 165.1 million in 2025 to USD 263.9 million, with Germany, the UK, and France at the forefront of regional growth.

Stakeholders Shaping the Future

The market's progress depends not just on manufacturers but also on a network of stakeholders. Governments are investing in healthcare infrastructure, incentivizing innovation through grants and R&D funding, and setting diagnostic standards that prioritize accuracy and safety. Industry bodies are working to standardize testing protocols, promote innovation, and develop talent pipelines for molecular diagnostics.

OEMs and technology integrators are designing platforms that combine hardware, software, and workflow optimization, while suppliers are scaling production and focusing on cost-effective solutions. Investors and financial enablers play a crucial role by funding next-generation technologies, expanding manufacturing capabilities, and supporting global distribution networks.

Purchase this Report for USD 5,000 Only | Get an Exclusive Discount Instantly! https://www.futuremarketinsights.com/checkout/26653

Everything You Need-within Your Budget. Request a Special Price Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-26653

Browse the Complete Report: https://www.futuremarketinsights.com/reports/mycobacterium-tuberculosis-pcr-detection-kits-market

Related Reports:

Patient Recliners Market: https://www.futuremarketinsights.com/reports/patient-recliners-market

Ureteral Stent Market: https://www.futuremarketinsights.com/reports/ureteral-stent-market

Dementia Care Products Market: https://www.futuremarketinsights.com/reports/dementia-care-products-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mycobacterium Tuberculosis PCR Kits Market to Hit USD 985.1 Million by 2035 with Diagnostics Innovation Driving Growth here

News-ID: 4213985 • Views:

More Releases from Future Market Insights

Japan Canola Lecithin Market to Reach USD 18.2 Million by 2035 Driven by Food, Pharmaceutical, and Cosmetic Applications
Japan Canola Lecithin Market to Reach USD 18.2 Million by 2035 Driven by Food, P …
Japan's canola lecithin market is entering a phase of steady expansion, supported by rising consumer demand for natural, clean-label emulsifiers and the growing use of plant-based ingredients across food, pharmaceutical, and cosmetics applications. Market projections show demand increasing from USD 14.2 million in 2025 to USD 18.2 million by 2035, driven by a shift toward healthier formulations and sustained growth in processed food and nutraceutical categories. Canola lecithin continues to gain
Japan Caramel Malt Market to Reach USD 77.4 Million by 2035 Driven by Craft Brewing and Specialty Beer Demand
Japan Caramel Malt Market to Reach USD 77.4 Million by 2035 Driven by Craft Brew …
Japan's caramel malt demand is experiencing consistent growth as breweries-both large-scale producers and craft operations-continue to rely on caramel malt for sweetness, foam stability, and refined roasted notes essential to Japan's evolving beer landscape. The market is valued at USD 56.8 million in 2025 and is projected to reach USD 77.4 million by 2035, driven by expanding flavor diversification and the prominence of malt-balanced beer styles across the country. Light-colour caramel
Japan Mineral Enrichment Ingredients Market to Reach USD 114.1 Billion by 2035 Driven by Aging Population and Health-Focused Consumption
Japan Mineral Enrichment Ingredients Market to Reach USD 114.1 Billion by 2035 D …
The demand for mineral enrichment ingredients in Japan is set to rise from USD 86.2 billion in 2025 to USD 114.1 billion by 2035, expanding at a consistent CAGR of 2.9%. This growth reflects Japan's long-standing emphasis on nutrition enhancement, healthy aging, and expanded use of fortified ingredients across food, beverage, and supplement categories. With consumers seeking functional, nutrient-dense foods, ingredients such as calcium, iron, magnesium, zinc, and trace minerals
Global Racing Bike Market to Reach USD 9.9 Billion by 2035, Driven by Performance Innovation and Competitive Cycling Momentum
Global Racing Bike Market to Reach USD 9.9 Billion by 2035, Driven by Performanc …
The global Racing Bike Market is entering a phase of steady, technology-led expansion, underpinned by rising participation in competitive cycling, increasing professional sponsorships, and accelerating innovation in lightweight bicycle engineering. The market is valued at USD 7.2 billion in 2025 and is forecast to reach USD 9.9 billion by 2035, expanding at a compound annual growth rate (CAGR) of 3.2% over the ten-year period. Market fundamentals remain strong as manufacturers align

All 5 Releases


More Releases for PCR

Emerging Trends to Reshape the Global Real-Time PCR, Digital PCR And End-Point P …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Real-Time PCR, Digital PCR And End-Point PCR Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market encompassing real-time PCR, digital PCR, and end-point PCR has experienced robust expansion over the past few years, projecting a rise from $38.37 billion in 2024 to $41.55 billion
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
The PCR And Realtime PCR Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current PCR And Realtime PCR Testing Market Size and Its Estimated Growth Rate? The PCR and real-time PCR testing market has grown strongly, rising from $10.55 billion in 2024
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size? There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size? There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is
Q-PCR and D-PCR Devices Market: Revolutionizing Molecular Diagnostics
The Q-PCR and D-PCR devices market has experienced significant growth in recent years, driven by advancements in molecular biology and the increasing demand for accurate and sensitive diagnostic tools. These technologies have revolutionized the field of molecular diagnostics, enabling researchers and clinicians to detect and quantify specific DNA or RNA sequences with high precision. Market Size and Growth The global Q-PCR and D-PCR devices market is estimated to be worth billions of
Real-Time PCR, Digital PCR And End-Point PCR Global Market Analysis, Trends, Gro …
The new report published by The Business Research Company, titled "Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the real-time pcr, digital pcr and end-point pcr market size has grown strongly